The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity.

This first population-level analysis of all primary adrenal malignancies provides important initial data regarding presentation and clinical outcomes. Notably, except for patients with NE, the survival of patients with these rare cancers has not improved over the past 40 years.